Literature DB >> 12842827

5,6-Dichloro-ribifuranosylbenzimidazole- and apigenin-induced sensitization of colon cancer cells to TNF-alpha-mediated apoptosis.

Myriam Farah1, Kuljit Parhar, Maryam Moussavi, Sharlene Eivemark, Baljinder Salh.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is a multifunctional cytokine involved in the expression of many genes integral to the inflammatory response. In addition, it activates both apoptotic and survival pathways, the latter being mediated through the activation of the transcription factor nuclear factor-kappaB (NF-kappaB). Protein kinase CK2, a serine-threonine kinase that is universally upregulated in human malignancies, may be involved at multiple levels in this process. However, its role in mediating a survival response within colon cancer cells remains incompletely understood. Here we report that inhibition of CK2 in HCT-116 and HT-29 cells with the use of two specific CK2 inhibitors, 5,6-dichloro-ribifuranosylbenzimidazole (DRB) and apigenin, effected a synergistic reduction in cell survival when used in conjunction with TNF-alpha. Furthermore, there was a demonstrable synergistic reduction in colony formation in soft agar with the use of the same combinations. Western blot analysis showed that poly-ADP ribose polymerase and procaspase-3 cleavage complemented the fluorescence-activated cell sorter analysis findings of significantly increased subdiploid DNA-containing cell populations using these conditions. Remarkably, these events occurred in the absence of any reduction in the expression of the Bcl-2 family members Bcl-2, Mcl-1, and Bcl-xL or any change in the proapoptotic molecules Bad or Bax. One-hybrid NF-kappaB promoter assays utilizing a Gal4-p65 transactivation domain construct revealed that the TNF-induced transactivation was inhibited by both DRB and apigenin. This was associated with a concomitant reduction in the expression of a recognized anti-apoptotic NF-kappaB target, manganese superoxide dismutase, demonstrated by Q-PCR. Our findings indicate a potentially novel strategy for the treatment of colon cancer, one that targets CK2 simultaneous with TNF-alpha administration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842827     DOI: 10.1152/ajpgi.00205.2003

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  17 in total

1.  Protein kinase casein kinase 2 mediates inhibitor-kappaB kinase and aberrant nuclear factor-kappaB activation by serum factor(s) in head and neck squamous carcinoma cells.

Authors:  Ming Yu; Jason Yeh; Carter Van Waes
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

2.  Disposition of flavonoids via enteric recycling: determination of the UDP-glucuronosyltransferase isoforms responsible for the metabolism of flavonoids in intact Caco-2 TC7 cells using siRNA.

Authors:  Xing Liu; Vincent H Tam; Ming Hu
Journal:  Mol Pharm       Date:  2007-10-10       Impact factor: 4.939

3.  B23 is a downstream target of polyamine-modulated CK2.

Authors:  Kathryn Lawson; Laura Larentowicz; Lisa Laury-Kleintop; Susan K Gilmour
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

4.  Apigenin suppresses the growth of colorectal cancer xenografts via phosphorylation and up-regulated FADD expression.

Authors:  Qi Rui Wang; Xue Qing Yao; Ge Wen; Qin Fan; Ying-Jia Li; Xiu Qiong Fu; Chang Ke Li; Xue Gang Sun
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

5.  Aldose reductase regulates TNF-alpha-induced PGE2 production in human colon cancer cells.

Authors:  Ravinder Tammali; Kota V Ramana; Satish K Srivastava
Journal:  Cancer Lett       Date:  2007-02-14       Impact factor: 8.679

6.  Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription.

Authors:  J C Tapia; V A Torres; D A Rodriguez; L Leyton; A F G Quest
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-27       Impact factor: 11.205

Review 7.  Apigenin: a promising molecule for cancer prevention.

Authors:  Sanjeev Shukla; Sanjay Gupta
Journal:  Pharm Res       Date:  2010-03-20       Impact factor: 4.200

8.  Plant flavone apigenin: An emerging anticancer agent.

Authors:  Eswar Shankar; Aditi Goel; Karishma Gupta; Sanjay Gupta
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

9.  Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells.

Authors:  Jin Dai; Peter G Van Wie; Leonard Yenwong Fai; Donghern Kim; Lei Wang; Pratheeshkumar Poyil; Jia Luo; Zhuo Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2016-09-20       Impact factor: 4.219

Review 10.  NF-kappaB and cancer: how intimate is this relationship.

Authors:  Sahdeo Prasad; Jayaraj Ravindran; Bharat B Aggarwal
Journal:  Mol Cell Biochem       Date:  2009-10-08       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.